Immunotherapeutic Agent

general

Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.

19

Centers

0

Active Trials

$1.8B

Cancer Funding

Specific Cancer Types(1)

NameCenters
Immunosuppressant4

Top Centers for Immunotherapeutic Agent(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Active Research Program
69.7
267.3
3
NCI Comprehensive
Active Research Program
65.0
4
Active Research Program
62.7
5
NCI Comprehensive
Active Research Program
60.3
6
NCI Comprehensive
Active Research Program
58.0
7
NCI Basic_laboratory
Active Research Program
55.7
8
Active Research Program
53.3
9
NCI Comprehensive
Active Research Program
51.0
10
NCI Comprehensive
Active Research Program
48.7
11
NCI Comprehensive
Active Research Program
46.3
12
NCI Comprehensive
Active Research Program
44.0
13
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
41.7
14
NCI Comprehensive
Active Research Program
39.3
15
NCI Basic_laboratory
Active Research Program
37.0
16
NCI Comprehensive
17
18
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
19
NCI Comprehensive

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →